nodes	percent_of_prediction	percent_of_DWPC	metapath
Terconazole—Myalgia—Nevirapine—acquired immunodeficiency syndrome	0.00504	0.00504	CcSEcCtD
Terconazole—Discomfort—Nevirapine—acquired immunodeficiency syndrome	0.00498	0.00498	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Didanosine—acquired immunodeficiency syndrome	0.0049	0.0049	CcSEcCtD
Terconazole—Arthralgia—Nelfinavir—acquired immunodeficiency syndrome	0.00488	0.00488	CcSEcCtD
Terconazole—Myalgia—Nelfinavir—acquired immunodeficiency syndrome	0.00488	0.00488	CcSEcCtD
Terconazole—Myalgia—Stavudine—acquired immunodeficiency syndrome	0.00487	0.00487	CcSEcCtD
Terconazole—Arthralgia—Stavudine—acquired immunodeficiency syndrome	0.00487	0.00487	CcSEcCtD
Terconazole—Anaphylactic shock—Nevirapine—acquired immunodeficiency syndrome	0.00483	0.00483	CcSEcCtD
Terconazole—Discomfort—Nelfinavir—acquired immunodeficiency syndrome	0.00482	0.00482	CcSEcCtD
Terconazole—Gastrointestinal pain—Amprenavir—acquired immunodeficiency syndrome	0.00482	0.00482	CcSEcCtD
Terconazole—Arthralgia—Abacavir—acquired immunodeficiency syndrome	0.0048	0.0048	CcSEcCtD
Terconazole—Myalgia—Abacavir—acquired immunodeficiency syndrome	0.0048	0.0048	CcSEcCtD
Terconazole—Chills—Indinavir—acquired immunodeficiency syndrome	0.00476	0.00476	CcSEcCtD
Terconazole—Discomfort—Abacavir—acquired immunodeficiency syndrome	0.00474	0.00474	CcSEcCtD
Terconazole—Abdominal pain—Amprenavir—acquired immunodeficiency syndrome	0.00466	0.00466	CcSEcCtD
Terconazole—Ill-defined disorder—Zidovudine—acquired immunodeficiency syndrome	0.00461	0.00461	CcSEcCtD
Terconazole—Anaphylactic shock—Abacavir—acquired immunodeficiency syndrome	0.0046	0.0046	CcSEcCtD
Terconazole—Pain—Didanosine—acquired immunodeficiency syndrome	0.0046	0.0046	CcSEcCtD
Terconazole—Malaise—Zidovudine—acquired immunodeficiency syndrome	0.00448	0.00448	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Nevirapine—acquired immunodeficiency syndrome	0.0044	0.0044	CcSEcCtD
Terconazole—Gastrointestinal pain—Didanosine—acquired immunodeficiency syndrome	0.0044	0.0044	CcSEcCtD
Terconazole—Chills—Delavirdine—acquired immunodeficiency syndrome	0.00431	0.00431	CcSEcCtD
Terconazole—Ill-defined disorder—Indinavir—acquired immunodeficiency syndrome	0.00429	0.00429	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Nelfinavir—acquired immunodeficiency syndrome	0.00426	0.00426	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Stavudine—acquired immunodeficiency syndrome	0.00425	0.00425	CcSEcCtD
Terconazole—Body temperature increased—Didanosine—acquired immunodeficiency syndrome	0.00425	0.00425	CcSEcCtD
Terconazole—Abdominal pain—Didanosine—acquired immunodeficiency syndrome	0.00425	0.00425	CcSEcCtD
Terconazole—Arthralgia—Zidovudine—acquired immunodeficiency syndrome	0.00423	0.00423	CcSEcCtD
Terconazole—Myalgia—Zidovudine—acquired immunodeficiency syndrome	0.00423	0.00423	CcSEcCtD
Terconazole—Asthenia—Amprenavir—acquired immunodeficiency syndrome	0.00423	0.00423	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Abacavir—acquired immunodeficiency syndrome	0.00419	0.00419	CcSEcCtD
Terconazole—Discomfort—Zidovudine—acquired immunodeficiency syndrome	0.00418	0.00418	CcSEcCtD
Terconazole—Pruritus—Amprenavir—acquired immunodeficiency syndrome	0.00417	0.00417	CcSEcCtD
Terconazole—Malaise—Indinavir—acquired immunodeficiency syndrome	0.00417	0.00417	CcSEcCtD
Terconazole—Pain—Nevirapine—acquired immunodeficiency syndrome	0.00413	0.00413	CcSEcCtD
Terconazole—Anaphylactic shock—Zidovudine—acquired immunodeficiency syndrome	0.00406	0.00406	CcSEcCtD
Terconazole—Ill-defined disorder—Efavirenz—acquired immunodeficiency syndrome	0.00405	0.00405	CcSEcCtD
Terconazole—Pain—Nelfinavir—acquired immunodeficiency syndrome	0.004	0.004	CcSEcCtD
Terconazole—Pain—Stavudine—acquired immunodeficiency syndrome	0.00399	0.00399	CcSEcCtD
Terconazole—Feeling abnormal—Nevirapine—acquired immunodeficiency syndrome	0.00398	0.00398	CcSEcCtD
Terconazole—Chills—Ritonavir—acquired immunodeficiency syndrome	0.00398	0.00398	CcSEcCtD
Terconazole—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	0.00396	0.00396	CcSEcCtD
Terconazole—Gastrointestinal pain—Nevirapine—acquired immunodeficiency syndrome	0.00395	0.00395	CcSEcCtD
Terconazole—Malaise—Efavirenz—acquired immunodeficiency syndrome	0.00394	0.00394	CcSEcCtD
Terconazole—Myalgia—Indinavir—acquired immunodeficiency syndrome	0.00393	0.00393	CcSEcCtD
Terconazole—Arthralgia—Indinavir—acquired immunodeficiency syndrome	0.00393	0.00393	CcSEcCtD
Terconazole—Pain—Abacavir—acquired immunodeficiency syndrome	0.00393	0.00393	CcSEcCtD
Terconazole—Discomfort—Indinavir—acquired immunodeficiency syndrome	0.00389	0.00389	CcSEcCtD
Terconazole—Ill-defined disorder—Delavirdine—acquired immunodeficiency syndrome	0.00388	0.00388	CcSEcCtD
Terconazole—Feeling abnormal—Nelfinavir—acquired immunodeficiency syndrome	0.00386	0.00386	CcSEcCtD
Terconazole—Asthenia—Didanosine—acquired immunodeficiency syndrome	0.00386	0.00386	CcSEcCtD
Terconazole—Urticaria—Nevirapine—acquired immunodeficiency syndrome	0.00384	0.00384	CcSEcCtD
Terconazole—Chills—Saquinavir—acquired immunodeficiency syndrome	0.00383	0.00383	CcSEcCtD
Terconazole—Gastrointestinal pain—Nelfinavir—acquired immunodeficiency syndrome	0.00383	0.00383	CcSEcCtD
Terconazole—Abdominal pain—Nevirapine—acquired immunodeficiency syndrome	0.00382	0.00382	CcSEcCtD
Terconazole—Body temperature increased—Nevirapine—acquired immunodeficiency syndrome	0.00382	0.00382	CcSEcCtD
Terconazole—Gastrointestinal pain—Stavudine—acquired immunodeficiency syndrome	0.00382	0.00382	CcSEcCtD
Terconazole—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.0038	0.0038	CcSEcCtD
Terconazole—Feeling abnormal—Abacavir—acquired immunodeficiency syndrome	0.00379	0.00379	CcSEcCtD
Terconazole—Anaphylactic shock—Indinavir—acquired immunodeficiency syndrome	0.00377	0.00377	CcSEcCtD
Terconazole—Malaise—Delavirdine—acquired immunodeficiency syndrome	0.00377	0.00377	CcSEcCtD
Terconazole—Gastrointestinal pain—Abacavir—acquired immunodeficiency syndrome	0.00376	0.00376	CcSEcCtD
Terconazole—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.00375	0.00375	CcSEcCtD
Terconazole—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	0.00372	0.00372	CcSEcCtD
Terconazole—Arthralgia—Efavirenz—acquired immunodeficiency syndrome	0.00372	0.00372	CcSEcCtD
Terconazole—Myalgia—Efavirenz—acquired immunodeficiency syndrome	0.00372	0.00372	CcSEcCtD
Terconazole—Rash—Amprenavir—acquired immunodeficiency syndrome	0.00372	0.00372	CcSEcCtD
Terconazole—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.00371	0.00371	CcSEcCtD
Terconazole—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.00371	0.00371	CcSEcCtD
Terconazole—Body temperature increased—Nelfinavir—acquired immunodeficiency syndrome	0.0037	0.0037	CcSEcCtD
Terconazole—Abdominal pain—Nelfinavir—acquired immunodeficiency syndrome	0.0037	0.0037	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Zidovudine—acquired immunodeficiency syndrome	0.0037	0.0037	CcSEcCtD
Terconazole—Headache—Amprenavir—acquired immunodeficiency syndrome	0.00369	0.00369	CcSEcCtD
Terconazole—Abdominal pain—Stavudine—acquired immunodeficiency syndrome	0.00369	0.00369	CcSEcCtD
Terconazole—Body temperature increased—Stavudine—acquired immunodeficiency syndrome	0.00369	0.00369	CcSEcCtD
Terconazole—Discomfort—Efavirenz—acquired immunodeficiency syndrome	0.00367	0.00367	CcSEcCtD
Terconazole—Chills—Lamivudine—acquired immunodeficiency syndrome	0.00366	0.00366	CcSEcCtD
Terconazole—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.00365	0.00365	CcSEcCtD
Terconazole—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	0.00363	0.00363	CcSEcCtD
Terconazole—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	0.00363	0.00363	CcSEcCtD
Terconazole—Ill-defined disorder—Ritonavir—acquired immunodeficiency syndrome	0.00359	0.00359	CcSEcCtD
Terconazole—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.00356	0.00356	CcSEcCtD
Terconazole—Arthralgia—Delavirdine—acquired immunodeficiency syndrome	0.00356	0.00356	CcSEcCtD
Terconazole—Myalgia—Delavirdine—acquired immunodeficiency syndrome	0.00356	0.00356	CcSEcCtD
Terconazole—Discomfort—Delavirdine—acquired immunodeficiency syndrome	0.00351	0.00351	CcSEcCtD
Terconazole—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.0035	0.0035	CcSEcCtD
Terconazole—Malaise—Ritonavir—acquired immunodeficiency syndrome	0.00348	0.00348	CcSEcCtD
Terconazole—Pain—Zidovudine—acquired immunodeficiency syndrome	0.00347	0.00347	CcSEcCtD
Terconazole—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.00347	0.00347	CcSEcCtD
Terconazole—Ill-defined disorder—Saquinavir—acquired immunodeficiency syndrome	0.00345	0.00345	CcSEcCtD
Terconazole—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.00345	0.00345	CcSEcCtD
Terconazole—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.00344	0.00344	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.00344	0.00344	CcSEcCtD
Terconazole—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.00342	0.00342	CcSEcCtD
Terconazole—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.00342	0.00342	CcSEcCtD
Terconazole—Rash—Didanosine—acquired immunodeficiency syndrome	0.00339	0.00339	CcSEcCtD
Terconazole—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.00339	0.00339	CcSEcCtD
Terconazole—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.00339	0.00339	CcSEcCtD
Terconazole—Headache—Didanosine—acquired immunodeficiency syndrome	0.00337	0.00337	CcSEcCtD
Terconazole—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.00336	0.00336	CcSEcCtD
Terconazole—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.00335	0.00335	CcSEcCtD
Terconazole—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.00335	0.00335	CcSEcCtD
Terconazole—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.00334	0.00334	CcSEcCtD
Terconazole—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.00332	0.00332	CcSEcCtD
Terconazole—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.00331	0.00331	CcSEcCtD
Terconazole—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.0033	0.0033	CcSEcCtD
Terconazole—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.0033	0.0033	CcSEcCtD
Terconazole—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.00329	0.00329	CcSEcCtD
Terconazole—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.00329	0.00329	CcSEcCtD
Terconazole—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.00329	0.00329	CcSEcCtD
Terconazole—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.00325	0.00325	CcSEcCtD
Terconazole—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.00325	0.00325	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.00325	0.00325	CcSEcCtD
Terconazole—Pain—Indinavir—acquired immunodeficiency syndrome	0.00323	0.00323	CcSEcCtD
Terconazole—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.00322	0.00322	CcSEcCtD
Terconazole—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.00321	0.00321	CcSEcCtD
Terconazole—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.00321	0.00321	CcSEcCtD
Terconazole—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.0032	0.0032	CcSEcCtD
Terconazole—Nausea—Didanosine—acquired immunodeficiency syndrome	0.00319	0.00319	CcSEcCtD
Terconazole—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.00317	0.00317	CcSEcCtD
Terconazole—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.00317	0.00317	CcSEcCtD
Terconazole—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.00313	0.00313	CcSEcCtD
Terconazole—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.00311	0.00311	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.00311	0.00311	CcSEcCtD
Terconazole—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.0031	0.0031	CcSEcCtD
Terconazole—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.00309	0.00309	CcSEcCtD
Terconazole—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.00308	0.00308	CcSEcCtD
Terconazole—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.00307	0.00307	CcSEcCtD
Terconazole—Pain—Efavirenz—acquired immunodeficiency syndrome	0.00305	0.00305	CcSEcCtD
Terconazole—Rash—Nevirapine—acquired immunodeficiency syndrome	0.00305	0.00305	CcSEcCtD
Terconazole—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.00304	0.00304	CcSEcCtD
Terconazole—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.00304	0.00304	CcSEcCtD
Terconazole—Headache—Nevirapine—acquired immunodeficiency syndrome	0.00303	0.00303	CcSEcCtD
Terconazole—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.00302	0.00302	CcSEcCtD
Terconazole—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.00302	0.00302	CcSEcCtD
Terconazole—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.003	0.003	CcSEcCtD
Terconazole—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.00298	0.00298	CcSEcCtD
Terconazole—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.00298	0.00298	CcSEcCtD
Terconazole—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.00298	0.00298	CcSEcCtD
Terconazole—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.00298	0.00298	CcSEcCtD
Terconazole—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.00297	0.00297	CcSEcCtD
Terconazole—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.00295	0.00295	CcSEcCtD
Terconazole—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.00295	0.00295	CcSEcCtD
Terconazole—Rash—Stavudine—acquired immunodeficiency syndrome	0.00294	0.00294	CcSEcCtD
Terconazole—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.00294	0.00294	CcSEcCtD
Terconazole—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.00294	0.00294	CcSEcCtD
Terconazole—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.00293	0.00293	CcSEcCtD
Terconazole—Headache—Stavudine—acquired immunodeficiency syndrome	0.00292	0.00292	CcSEcCtD
Terconazole—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.00292	0.00292	CcSEcCtD
Terconazole—Pain—Delavirdine—acquired immunodeficiency syndrome	0.00292	0.00292	CcSEcCtD
Terconazole—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.00291	0.00291	CcSEcCtD
Terconazole—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.00291	0.00291	CcSEcCtD
Terconazole—Rash—Abacavir—acquired immunodeficiency syndrome	0.0029	0.0029	CcSEcCtD
Terconazole—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.0029	0.0029	CcSEcCtD
Terconazole—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.0029	0.0029	CcSEcCtD
Terconazole—Headache—Abacavir—acquired immunodeficiency syndrome	0.00288	0.00288	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.00287	0.00287	CcSEcCtD
Terconazole—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.00287	0.00287	CcSEcCtD
Terconazole—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.00287	0.00287	CcSEcCtD
Terconazole—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.00283	0.00283	CcSEcCtD
Terconazole—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.00282	0.00282	CcSEcCtD
Terconazole—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.00282	0.00282	CcSEcCtD
Terconazole—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.00281	0.00281	CcSEcCtD
Terconazole—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.00279	0.00279	CcSEcCtD
Terconazole—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.00278	0.00278	CcSEcCtD
Terconazole—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.00278	0.00278	CcSEcCtD
Terconazole—Nausea—Stavudine—acquired immunodeficiency syndrome	0.00277	0.00277	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.00277	0.00277	CcSEcCtD
Terconazole—Nausea—Abacavir—acquired immunodeficiency syndrome	0.00273	0.00273	CcSEcCtD
Terconazole—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.00271	0.00271	CcSEcCtD
Terconazole—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.00271	0.00271	CcSEcCtD
Terconazole—Pain—Ritonavir—acquired immunodeficiency syndrome	0.0027	0.0027	CcSEcCtD
Terconazole—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.0027	0.0027	CcSEcCtD
Terconazole—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.0027	0.0027	CcSEcCtD
Terconazole—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.00268	0.00268	CcSEcCtD
Terconazole—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.00267	0.00267	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.00264	0.00264	CcSEcCtD
Terconazole—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.00263	0.00263	CcSEcCtD
Terconazole—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.0026	0.0026	CcSEcCtD
Terconazole—Pain—Saquinavir—acquired immunodeficiency syndrome	0.0026	0.0026	CcSEcCtD
Terconazole—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.00258	0.00258	CcSEcCtD
Terconazole—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.00258	0.00258	CcSEcCtD
Terconazole—Rash—Zidovudine—acquired immunodeficiency syndrome	0.00256	0.00256	CcSEcCtD
Terconazole—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.00256	0.00256	CcSEcCtD
Terconazole—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.00256	0.00256	CcSEcCtD
Terconazole—Headache—Zidovudine—acquired immunodeficiency syndrome	0.00254	0.00254	CcSEcCtD
Terconazole—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.00252	0.00252	CcSEcCtD
Terconazole—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.00251	0.00251	CcSEcCtD
Terconazole—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.00251	0.00251	CcSEcCtD
Terconazole—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.0025	0.0025	CcSEcCtD
Terconazole—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.00249	0.00249	CcSEcCtD
Terconazole—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.00249	0.00249	CcSEcCtD
Terconazole—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.00249	0.00249	CcSEcCtD
Terconazole—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.00248	0.00248	CcSEcCtD
Terconazole—Pain—Lamivudine—acquired immunodeficiency syndrome	0.00248	0.00248	CcSEcCtD
Terconazole—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.00245	0.00245	CcSEcCtD
Terconazole—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.00241	0.00241	CcSEcCtD
Terconazole—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.00241	0.00241	CcSEcCtD
Terconazole—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.00241	0.00241	CcSEcCtD
Terconazole—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.0024	0.0024	CcSEcCtD
Terconazole—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.0024	0.0024	CcSEcCtD
Terconazole—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.0024	0.0024	CcSEcCtD
Terconazole—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.00239	0.00239	CcSEcCtD
Terconazole—Rash—Indinavir—acquired immunodeficiency syndrome	0.00238	0.00238	CcSEcCtD
Terconazole—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.00238	0.00238	CcSEcCtD
Terconazole—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.00237	0.00237	CcSEcCtD
Terconazole—Headache—Indinavir—acquired immunodeficiency syndrome	0.00236	0.00236	CcSEcCtD
Terconazole—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.00236	0.00236	CcSEcCtD
Terconazole—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.00232	0.00232	CcSEcCtD
Terconazole—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.0023	0.0023	CcSEcCtD
Terconazole—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.00229	0.00229	CcSEcCtD
Terconazole—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.00229	0.00229	CcSEcCtD
Terconazole—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.00227	0.00227	CcSEcCtD
Terconazole—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.00226	0.00226	CcSEcCtD
Terconazole—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.00225	0.00225	CcSEcCtD
Terconazole—Rash—Efavirenz—acquired immunodeficiency syndrome	0.00225	0.00225	CcSEcCtD
Terconazole—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.00225	0.00225	CcSEcCtD
Terconazole—Nausea—Indinavir—acquired immunodeficiency syndrome	0.00224	0.00224	CcSEcCtD
Terconazole—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.00224	0.00224	CcSEcCtD
Terconazole—Headache—Efavirenz—acquired immunodeficiency syndrome	0.00223	0.00223	CcSEcCtD
Terconazole—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.00223	0.00223	CcSEcCtD
Terconazole—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.00218	0.00218	CcSEcCtD
Terconazole—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.00217	0.00217	CcSEcCtD
Terconazole—Rash—Delavirdine—acquired immunodeficiency syndrome	0.00215	0.00215	CcSEcCtD
Terconazole—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.00215	0.00215	CcSEcCtD
Terconazole—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.00215	0.00215	CcSEcCtD
Terconazole—Headache—Delavirdine—acquired immunodeficiency syndrome	0.00214	0.00214	CcSEcCtD
Terconazole—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.00213	0.00213	CcSEcCtD
Terconazole—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.00212	0.00212	CcSEcCtD
Terconazole—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.00209	0.00209	CcSEcCtD
Terconazole—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.00208	0.00208	CcSEcCtD
Terconazole—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.00205	0.00205	CcSEcCtD
Terconazole—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.00203	0.00203	CcSEcCtD
Terconazole—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.00201	0.00201	CcSEcCtD
Terconazole—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.002	0.002	CcSEcCtD
Terconazole—Rash—Ritonavir—acquired immunodeficiency syndrome	0.00199	0.00199	CcSEcCtD
Terconazole—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.00199	0.00199	CcSEcCtD
Terconazole—Headache—Ritonavir—acquired immunodeficiency syndrome	0.00198	0.00198	CcSEcCtD
Terconazole—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.00193	0.00193	CcSEcCtD
Terconazole—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.00191	0.00191	CcSEcCtD
Terconazole—Rash—Saquinavir—acquired immunodeficiency syndrome	0.00191	0.00191	CcSEcCtD
Terconazole—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.00191	0.00191	CcSEcCtD
Terconazole—Headache—Saquinavir—acquired immunodeficiency syndrome	0.0019	0.0019	CcSEcCtD
Terconazole—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.00187	0.00187	CcSEcCtD
Terconazole—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.00184	0.00184	CcSEcCtD
Terconazole—Rash—Lamivudine—acquired immunodeficiency syndrome	0.00183	0.00183	CcSEcCtD
Terconazole—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.00182	0.00182	CcSEcCtD
Terconazole—Headache—Lamivudine—acquired immunodeficiency syndrome	0.00181	0.00181	CcSEcCtD
Terconazole—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.0018	0.0018	CcSEcCtD
Terconazole—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.00172	0.00172	CcSEcCtD
